Table 2.
The mNGS results of bacteria and fungi for patients without paired BALF culture result (n = 10).
| Patient ID | BALF mNGS result | SMRN | Blood mNGS result | SMRN | Clinical diagnosis | Changes in treatment |
|---|---|---|---|---|---|---|
| 03 | Stenotrophomonas maltophilia | 14 | — | — | HAP | Discontinuation of Tigecycline |
| Candida albicans | 6 | |||||
| 05 | Candida tropicalis | 5 | — | — | HAP | No change |
| 06 | — | — | Pneumocystis jirovecii | 40 | PJP | No change |
| 15 | — | — | — | — | CAP | Discontinuation of Amphotericin B |
| 30 | Candida tropicalis | 49 | — | — | HAP | No change |
| Candida glabrata | 4 | |||||
| 33 | Pneumocystis jirovecii | 123887 | Pneumocystis jirovecii | 417 | PJP Bacterial infection |
No change |
| Acinetobacter baumannii | 553 | |||||
| Escherichia coli | 27 | |||||
| 36 | — | — | — | CAP | No change | |
| 37 | — | — | Acinetobacter baumannii | 6 | CAP | No change |
| 38 | — | — | — | — | HAP | No change |
| 39 | — | — | — | — | Aspiration pneumonia | No change |
Abbreviations: mNGS, metagenomic next-generation sequencing; SMRN, number of reads stringently mapped to pathogen species; PJP, Pneumocystis jirovecii Pneumonia; CAP, community-acquired pneumonia; HAP, hospital-acquired pneumonia.